Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT03903822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2B, RANDOMIZED, DOUBLE BLIND, VEHICLE CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06700841 CREAM APPLIED ONCE OR TWICE DAILY FOR 6 WEEKS IN PARTICIPANTS WITH MILD OR MODERATE ATOPIC DERMATITIS
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to provide data on efficacy, safety, tolerability and PK of multiple topical formulation concentrations of PF-06700841 topical cream in the treatment of mild to moderate atopic dermatitis (AD). The study is intended to enable selection of the dose and dosing regimen (once daily \[QD\] vs twice daily \[BID\] application) for the future clinical development of topical PF-06700841.
Study identification
- NCT ID
- NCT03903822
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 292 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 13, 2019 (Actual)
- Primary completion
- May 7, 2020 (Actual)
- Completion
- May 7, 2020 (Actual)
- Last update posted
- Mar 29, 2021
2019 – 2020
United States locations
- U.S. sites
- 36
- U.S. states
- 18
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Alabama, LLC | Birmingham | Alabama | 35244 | — |
| Center for Dermatology and Plastic Surgery/CCT | Scottsdale | Arizona | 85260 | — |
| Center for Dermatology and Plastic Surgery | Scottsdale | Arizona | 85260 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Beach Allergy and Asthma Specialty Group, A Medical Corporation | Long Beach | California | 90808 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| New England Associates, LLC | Bridgeport | Connecticut | 06606 | — |
| Dermatology Physicians of Connecticut | Shelton | Connecticut | 06484 | — |
| Yolanda C. Holmes, MD | Washington D.C. | District of Columbia | 20036 | — |
| Olympian Clinical Research | Clearwater | Florida | 33756 | — |
| Accel Research Sites - DeLand Clinical Research Unit | DeLand | Florida | 32720 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Clinical Neuroscience Solutions, Inc. | Jacksonville | Florida | 32256 | — |
| Precision Imaging | Jacksonville | Florida | 32256 | — |
| Solutions Through Advanced Research, Inc | Jacksonville | Florida | 32256 | — |
| Clinical Neuroscience Solutions, Inc. | Orlando | Florida | 32801 | — |
| Leavitt Medical Associates of Florida d/b/a Ameriderm Research | Ormond Beach | Florida | 32174 | — |
| Advanced Medical Research PC | Sandy Springs | Georgia | 30328 | — |
| Sneeze, Wheeze & Itch Associates, LLC | Normal | Illinois | 61761 | — |
| DS Research | New Albany | Indiana | 47150 | — |
| DS Research | Louisville | Kentucky | 40241 | — |
| Meridian Clinical Research, LLC | Baton Rouge | Louisiana | 70808 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Dermatology Consulting Services, PLLC | High Point | North Carolina | 27262 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 74136 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Tanenbaum Dermatology Center | Memphis | Tennessee | 38117 | — |
| Clinical Neuroscience Solutions, Inc. | Memphis | Tennessee | 38119 | — |
| studies in Dermatology, LLC | Cypress | Texas | 77433 | — |
| Center for Clinical Studies, LTD.LLP | Houston | Texas | 77004 | — |
| Ventavia Research Group LLC | Hurst | Texas | 76054 | — |
| Center for Clinical Studies, LTD. LLP | Webster | Texas | 77598 | — |
| Summit Clinical Research, LLC | Franklin | Virginia | 23851 | — |
| Virginia Dermatology and Skin Cancer Center | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03903822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03903822 live on ClinicalTrials.gov.